tirzepatide approved for osa the Treatment of Obstructive Sleep Apnea and Obesity Diabetes drug resolves sleep apnea

This gap has catalyzed significant R&D investment in muscle-sparing adjuncts, including myostatin inhibitors and ActRII pathway modulators that could be combined with GLP-1 agonists to preserve lean mass while maintaining fat loss efficacy

All authors had full access to all of the data in this study and take complete responsibility for the integrity of the data and accuracy of the data analysis

This is the evidence-based range for muscle maintenance during a deficit

Ozempic is FDA-approved for chronic weight management, while Wegovy is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss at a providers discretion